PCK1 activates oncogenic autophagy via down-regulation Serine phosphorylation of UBAP2L and antagonizes colorectal cancer growth
Abstract Phosphoenolpyruvate carboxykinase 1 (PCK1) is the rate-limiting enzyme in gluconeogenesis. PCK1 is considered an anti-oncogene in several human cancers. In this study, we aimed to determine the functions of PCK1 in colorectal cancer (CRC). PCK1 expression in CRC tissues was tested by wester...
Main Authors: | Xiangyan Zhang, Geru Tao, Jie Jiang, Tingting Qu, Shuchao Zhao, Ping Xu, Ya’nan Zhao, Xiaoming Xing, Shucun Qin |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
BMC
2023-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Acceso en liña: | https://doi.org/10.1186/s12935-023-02894-x |
Títulos similares
-
Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families
por: Marwa Al Busaidi, et al.
Publicado: (2023-11-01) -
The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment
por: Romina Bertinat, et al.
Publicado: (2025-04-01) -
Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
por: Yufu Tang, et al.
Publicado: (2018-05-01) -
PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner
por: Petra Hyroššová, et al.
Publicado: (2021-01-01) -
Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
por: Toshiki Namiki, et al.
Publicado: (2023-10-01)